[1] Guillemaud JP, Patel RS, Goldstein DP, et al. Prognostic impact of intraoperative microscopic cut-through on frozen section in oral cavity squamous cell carcinoma [J]. J Otolaryngol Head Neck Surg, 2010, 39(4): 370-377. [2] Chandran UR, Dhir R, Ma C, et al. Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors[J]. BMC Cancer, 2005, 5: 45. [3] 李锐, 陈卫昌, 刘强, 等. 胃癌和癌旁组织CD40表达及其生物学意义 [J]. 肿瘤学杂志, 2005, 11(2): 120-122. [4] Xu Y, Liu AJ, Gao YX, et al. Expression of Ku86 and presence of Ku86 antibody as biomarkers of hepatitis B virus related hepatocellular carcinoma [J]. Dig Dis Sci, 2014, 59(3): 614-622. [5] Nathan CO , Franklin S, Abreo FW, et al. Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer[J]. J Clin Oncol, 1999,17(9): 2909-2914. [6] Akino T, Hida K, Hida Y, et al. Cytogenetic abnormalities of tumor-associated endothelial cells in human malignant tumor [J]. Am J Pathol, 2009, 175(6): 2657-2667. [7] Bignold LP. Mutation, replicative infidelity of DNA and aneuploidy sequentially in the formation of malignant pleomorphic tumors [J]. Histol Histopathol, 2007, 22(3): 321-326. [8] Abou-Elhamd KE, Habib TN. The flow cytometric analysis of premalignant and malignant lesion in head and neck squamous cell carcinoma [J]. Oral Oncol, 2007, 43(4): 366-372. [9] Piemonte M. TNM-classification of malignant tumors (VI edition -2002). Innovations in the classification of head and neck neoplasms [J]. Acta Otorhinolaryngol Ital, 2003, 23(2): 132-135. [10] French DL, Ramos-DeSimone N, Rozinski K, et al. Matrix metalloproteinase-9 in tumor cell invasion [J]. Ann N Y Acad Sci, 1994, 732: 324-334. [11] Sinicrope FA, Ruan SB, Karen R, et al. Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis [J]. Cancer Res, 1995, 55(2): 237-241. [12] McDowell JD. An overview of epidemiology and common risk factors for oral squamous cell carcinoma [J]. Otolaryngol Clin North Am, 2006, 39(2): 277-294. [13] Yanamoto S, Yamada S, Takahashi H, et al. Clinicopathological risk factors for local recurrence in oral squamous cell carcinoma [J]. Int J oral Max Surg, 2012, 41(10): 1195-1200. [14] Brandwein-Gensler M, Teixeira MS, Lewis CM, et al. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival [J]. Am J Surg Pathol, 2005, 29(2): 167-178. [15] Jacobs JR, Ahmed K, Casiano R, et al. Implications of positive surgical margins [J]. Laryngoscope, 1993, 103(1 Pt 1): 64-68. [16] Sorrells DL Jr, Ghali GE, De Benedetti A, et al. Progressive amplification and overexpression of the eukaryotic initiation factor 4E gene in different zones of head and neck cancers [J]. J Oral Maxillofac Surg, 1999, 57(3): 294-299. [17] Chandy B, Abreo F, Nassar R, et al. Expression of the proto-oncogene eIF4E in inflammation of the oral cavity [J]. Otolaryngol Head Neck Surg, 2002, 126(3): 290-295. [18] Sunavala-Dossabhoy G, Palaniyandi S, Clark C, et al. Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer [J]. Laryngoscope, 2011, 121(10): 2136-2141. [19] Nathan CO, Liu L, Li BD, et al. Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer [J]. Oncogene, 1997, 15(5): 579-584. |